Navigation Links
FDA warnings against use of antipsychotic drugs for elderly,,

The Food and Drug Administration (FDA) of US had warned the public and medical professionals against use of //certain drugs broadly called as atypical antipsychotic drugs on elderly patients with dementia.

The drugs, aripiprazole, olanzapine, quetiapine, risperidone, clozapine and ziprasidone, are approved for the clinical treatment of schizophrenia and mania. Use of these drugs to treat elderly patients with dementia and behavior disorders have resulted in a very high incidence of deaths. Studies conducted had showed that the drugs are as much as 1.6 times riskier than that of any other drugs. These drugs which again can be divided into three classes based on their composition, are all equally have a high risk of death due to cardiac problems associated with them when used on geriatric patients.

FDA has requested that the manufacturers of these drugs do change the label of these medications to include the warning against use of them in geriatric patients with dementia. The warning must be boxed to catch the maximum attention and must say that they are not approved for treating the behavioral disorders associated with dementia. The organization had also requested the physicians prescribing these drugs for behavioral problems in elderly to review the situation.

Reference: : Food and Drug Administration, US, news release

Page: 1

Related medicine news :

1. Fresh warnings to doctors regarding abortion pill
2. Opposition: Government turned a deaf ear to warnings about dwindling health care services
3. FDA issues warnings on Three Popular Asthma drug labels
4. Anlene brand of milk products will carry warnings about blood-clotting risks
5. The need for cancer warnings on alcohol packaging
6. Graphic warnings on cigarette packets might just do the trick!
7. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
8. Man against HIV – new vaccine ready for human trials
9. Antibiotics losing their power against acne
10. South Africa Wins landmark case against pharmaceutical giants
11. Vitamin E, the latest warrior against diabetes
Post Your Comments:

(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: